Business / Finance

RSS

Baxter International acquires drug candidate developed to treat sickle cell disease

A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business.

11 Jul 2014

Aviv acquires two ALFs and one post-acute and long-term care SNF for $82 million

Aviv REIT, Inc. announced today it has acquired two assisted living facilities ("ALFs") and one post-acute and long-term care skilled nursing facility ("SNF") for $82.0 million (the "Acquisition"), and two parcels of land and the entitlements for the construction of two new ALFs and a 50 unit addition to one of the existing ALFs for $12.2 million (the "New Construction Projects"), all of which are located in Massachusetts, for a total of $94.2 million.

11 Jul 2014

Mercy Memorial Hospital System signs LOI to join Promedica

Mercy Memorial Hospital System signed a letter of intent to join ProMedica, a not-for-profit, multi-hospital system based in Toledo, Ohio.

9 Jul 2014

Battelle acquires nearly 11% of AMIC's outstanding Common Stock

Advanced Medical Isotope Corporation, a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that Battelle, has acquired approximately 11% of AMIC's outstanding Common Stock.

7 Jul 2014

Hospira acquires API manufacturing and R&D facilities from Orchid for about $218 million

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $218 million, after settling prior advances of approximately $30 million.

7 Jul 2014

BBSRC announce launch of Crossing Biological Membranes’ network

The BBSRC, with support from EPSRC, have committed £18M to fund 13 unique collaborative Networks in Industrial Biotechnology and Bioenergy (BBSRC NIBB).

4 Jul 2014

TxCell announces launch of POSITIVE project to automate manufacturing process for Ovasave

TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today the launch of, and funding awarded to, the POSITIVE project in collaboration with the Gene and Cell therapy Unit (UTCG) developing new antiviral cell-based immunotherapies and Biosafe, a Swiss private company, a developer of innovative solutions for cell processing.

4 Jul 2014

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, a global biopharmaceutical leader, and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia (certolizumab pegol) in dermatology.

3 Jul 2014

Forest Laboratories completes acquisition of Furiex Pharmaceuticals

Actavis plc today announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex Pharmaceuticals, Inc. in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right (CVR) that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug following approval.

2 Jul 2014

Eurofins Genomics, AmpTec sign co-marketing agreement for IVT-RNAs

Eurofins Genomics, international market leader in genomic services, and AmpTec, internationally recognized provider of RNA technology products, have agreed on non-exclusively co-marketing AmpTec's IVT-RNAs globally.

2 Jul 2014

Genentech agrees to acquire Seragon Pharmaceuticals

Genentech, a member of the Roche Group, today announced it has entered into a definitive agreement to acquire Seragon Pharmaceuticals, Inc., a privately held biotechnology company based in San Diego, California.

2 Jul 2014

Rotation Medical secures $27.2 million in oversubscribed Series B financing

Rotation Medical, a medical device company focused on developing new technologies to treat rotator cuff disease, today announced that it has secured $27.2 million in an oversubscribed Series B financing.

1 Jul 2014

Telerx acquires C3i to expand business services outside the United States

Telerx, a leader in U.S. customer care services, today announced that it has completed its acquisition of C3i, a leading provider of technology support services for the life sciences industry. This acquisition will provide Telerx with the global infrastructure to expand its business services outside the United States while maintaining its current domestic operations. The acquisition was completed on June 30, 2014.

1 Jul 2014

Cerus enters into $30M growth capital credit facility with Oxford Finance

Cerus Corporation announced today that it has entered into a $30 million growth capital credit facility with Oxford Finance LLC.

1 Jul 2014

Capital Senior Living purchases three communities, closes debt refinance

Capital Senior Living Corporation (the "Company"), one of the country's largest operators of senior living communities, today announced that the Company has purchased three senior living communities located in Ohio from joint ventures in which it held a 10 percent interest (the "Ohio JV Communities") for a purchase price of $83.6 million.

1 Jul 2014

PuriCore International acquired by Cantel Medical

Cantel Medical Corp., today announced that the company has successfully completed the acquisition of PuriCore International Limited., a wholly-owned subsidiary of PuriCore plc.

1 Jul 2014

FSC Laboratories acquires exclusive marketing rights for Aciphex Sprinkle in the U.S.

FSC Therapeutics, LLC, today announced that the Company has entered into a transaction with Eisai Inc. to acquire exclusive U.S. marketing rights for AcipHex® Sprinkle™ (rabeprazole sodium), Delayed-Release Capsules, 5 mg and 10 mg, for the treatment of Gastroesophageal Reflux Disease (GERD) in children 1 to 11 years of age for up to 12 weeks.

30 Jun 2014

Medican Enterprises is in negotiations to purchase 51% of International Herbs Medical Marijuana

Medican Enterprises, Inc. a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce it is currently negotiating the purchase of 51% of International Herbs Medical Marijuana Ltd ("IHMML").

30 Jun 2014

Stryker Corporation to acquire all assets of Small Bone Innovations for $375M

Small Bone Innovations, Inc. (SBi) today announced that Stryker Corporation will acquire substantially all the assets of SBi in an all cash transaction for up to $375 million.

From Stryker 30 Jun 2014

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has completed a $32 million Series A financing that will enable it to advance candidates from the company's Cloudbreak™ targeted immunotherapy platform and biafungin™, a novel long acting echinocandin antifungal drug, into human clinical studies.

30 Jun 2014

Business / Finance

Baxter International acquires drug candidate developed to treat sickle cell disease

Aviv acquires two ALFs and one post-acute and long-term care SNF for $82 million

Mercy Memorial Hospital System signs LOI to join Promedica

Battelle acquires nearly 11% of AMIC's outstanding Common Stock

Hospira acquires API manufacturing and R&D facilities from Orchid for about $218 million

BBSRC announce launch of Crossing Biological Membranes’ network

TxCell announces launch of POSITIVE project to automate manufacturing process for Ovasave

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

Forest Laboratories completes acquisition of Furiex Pharmaceuticals

Eurofins Genomics, AmpTec sign co-marketing agreement for IVT-RNAs

Genentech agrees to acquire Seragon Pharmaceuticals

Rotation Medical secures $27.2 million in oversubscribed Series B financing

Telerx acquires C3i to expand business services outside the United States

Cerus enters into $30M growth capital credit facility with Oxford Finance

Capital Senior Living purchases three communities, closes debt refinance

PuriCore International acquired by Cantel Medical

FSC Laboratories acquires exclusive marketing rights for Aciphex Sprinkle in the U.S.

Medican Enterprises is in negotiations to purchase 51% of International Herbs Medical Marijuana

Stryker Corporation to acquire all assets of Small Bone Innovations for $375M

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News